Funder
Johnson & Johnson Consumer Healthcare
Perrigo Co Plc
Ortho McNeil Janssen Pharmaceuticals Inc
Reference25 articles.
1. Loperamide (ADL 2–1294), an opioid antihyperalgesic agent with peripheral selectivity;DeHaven-Hudkins;J Pharmacol Exp Ther,1999
2. Loperamide: a pharmacological review;Baker;Rev Gastroenterol Disord,2007
3. Safety and efficacy of loperamide;Ericsson;Am J Med,1990
4. Abuse potential of loperamide;Jaffe;Clin Pharmacol Ther,1980
5. Electrocardiographic changes in loperamide toxicity: case report and review of literature;Teigeler;J Cardiovasc Electrophysiol,2019